Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.0.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
IPO
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2019       $ 4,989 $ (6,147) $ (1,158)
Beginning balance (in shares) at Dec. 31, 2019   10,211,658        
Changes in Stockholders' deficit            
Issuance of common stock       83   83
Issuance of common stock (in shares) 3,430,000 15,726        
Offering costs in connection with public offering       (3,183)   (3,183)
Issuance of common stock for the purchase of Verus       252   252
Issuance of common stock for the purchase of Verus (in shares)   12,662        
Purchase of treasury stock     $ (30)     (30)
Purchase of treasury stock (in shares)   (5,683) 5,683      
Share-based compensation, net of forfeitures       728   728
Share-based compensation, net of forfeitures (in shares)   165,988        
Issuance of common stock in connection with IPO       34,300   34,300
Issuance of common stock in connection with IPO (in shares)   3,430,000        
Net loss attributable to common stock-basic and diluted         (1,341) (1,341)
Ending balance at Dec. 31, 2020     $ (30) 37,169 (7,488) 29,651
Ending balance (in shares) at Dec. 31, 2020   13,830,351 5,683      
Changes in Stockholders' deficit            
Issuance of common stock (in shares) 1,400,000          
Offering costs in connection with public offering       (2,471)   (2,471)
Issuance of common stock for the purchase of Verus       25,538   25,538
Issuance of common stock for the purchase of Verus (in shares)   777,380        
Issuance of common stock pursuant to exercise of stock options       80   $ 80
Issuance of common stock pursuant to exercise of stock options (in shares)   16,972       16,974
Share-based compensation, net of forfeitures       4,843   $ 4,843
Share-based compensation, net of forfeitures (in shares)   376,903        
Issuance of common stock in connection with IPO       35,000   35,000
Issuance of common stock in connection with IPO (in shares)   1,750,000        
Net loss attributable to common stock-basic and diluted         (12,491) (12,491)
Ending balance at Dec. 31, 2021     $ (30) $ 100,159 $ (19,979) $ 80,150
Ending balance (in shares) at Dec. 31, 2021   16,751,606 5,683